Signum Surgical wins €3.6 million grants for colorectal disease therapy

Signum Surgical, which is developing minimally invasive technologies to treat colorectal diseases, has secured two grants totalling €3.6 million:  €2.3 million from the EU Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund. 

First EU citizens using cross-border ePrescriptions

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country. Finnish citizens are now able to retrieve medicine prescribed by a doctor in Finland from a pharmacy in Estonia with ePrescriptions.
WeHealth by Servier and Pathmaker Neurosystems collaborating to treat spasticity
WeHealth by Servier and Pathmaker Neurosystems have formed a partnership to develop and commercialise Pathmaker's MyoRegulator device, a non-invasive treatment for spasticity. 
Alex Guest Thu, 10/01/2019 - 09:26